NO973421L - Rekombinant DNA omfattende DNA som koder for myosin tungkjede SM1-isoformt protein innskutt i vektor DNA, mikroorganisme som inneholder det rekombinante DNA og et middel for behandling av arteriosklerose omfattende det rekombinante DNA - Google Patents

Rekombinant DNA omfattende DNA som koder for myosin tungkjede SM1-isoformt protein innskutt i vektor DNA, mikroorganisme som inneholder det rekombinante DNA og et middel for behandling av arteriosklerose omfattende det rekombinante DNA

Info

Publication number
NO973421L
NO973421L NO973421A NO973421A NO973421L NO 973421 L NO973421 L NO 973421L NO 973421 A NO973421 A NO 973421A NO 973421 A NO973421 A NO 973421A NO 973421 L NO973421 L NO 973421L
Authority
NO
Norway
Prior art keywords
dna
recombinant dna
heavy chain
recombinant
myosin heavy
Prior art date
Application number
NO973421A
Other languages
English (en)
Other versions
NO973421D0 (no
Inventor
Kazuhide Hasegawa
Emi Arakawa
Shoji Oda
Yuzuru Matsuda
Katsuhito Talahashi
Haruo Ishiyama
Michihiro Sugahara
Original Assignee
Vessel Research Lab Co Ltd
Osaka Prefecture
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vessel Research Lab Co Ltd, Osaka Prefecture filed Critical Vessel Research Lab Co Ltd
Publication of NO973421D0 publication Critical patent/NO973421D0/no
Publication of NO973421L publication Critical patent/NO973421L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4716—Muscle proteins, e.g. myosin, actin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Plant Pathology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Det beskrives rekombinant DNA som omfatter DNA som koder for glattmuskel-type myosin tungkjede SM1-isoformt protein innskutt i vektor DNA, en mikroorganisme som bærer den rekombinante DNA og et middel for behandling av arteriosklerose, som omfatter den rekombinante DNA. Denne rekombinante DNA kan benyttes effektivt som et middel ved genterapi ved restenose etter PTCA-behandling.
NO973421A 1995-01-25 1997-07-24 Rekombinant DNA omfattende DNA som koder for myosin tungkjede SM1-isoformt protein innskutt i vektor DNA, mikroorganisme som inneholder det rekombinante DNA og et middel for behandling av arteriosklerose omfattende det rekombinante DNA NO973421L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP1008595 1995-01-25
PCT/JP1996/000134 WO1996023069A1 (fr) 1995-01-25 1996-01-25 Adn de recombinaison prepare par integration d'adn qui code une proteine isoforme sm1 a chaine lourde de myosine dans un vecteur d'adn, et micro-organisme et remede contre l'arteriosclerose contenant tous deux ledit adn de recombinaison

Publications (2)

Publication Number Publication Date
NO973421D0 NO973421D0 (no) 1997-07-24
NO973421L true NO973421L (no) 1997-09-22

Family

ID=11740510

Family Applications (1)

Application Number Title Priority Date Filing Date
NO973421A NO973421L (no) 1995-01-25 1997-07-24 Rekombinant DNA omfattende DNA som koder for myosin tungkjede SM1-isoformt protein innskutt i vektor DNA, mikroorganisme som inneholder det rekombinante DNA og et middel for behandling av arteriosklerose omfattende det rekombinante DNA

Country Status (13)

Country Link
US (1) US6593304B1 (no)
EP (1) EP0806477B1 (no)
JP (1) JP3092944B2 (no)
KR (1) KR19980701695A (no)
AT (1) ATE236977T1 (no)
AU (1) AU711757B2 (no)
CA (1) CA2211468A1 (no)
DE (1) DE69627307T2 (no)
FI (1) FI973104A (no)
HU (1) HUP9801762A1 (no)
NO (1) NO973421L (no)
NZ (1) NZ300270A (no)
WO (1) WO1996023069A1 (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11285333A (ja) * 1998-02-05 1999-10-19 Vessel Research Laboratory:Kk 変異型平滑筋ミオシン重鎖遺伝子を有する非ヒト動物の胚幹細胞および非ヒト動物
CN1321672A (zh) * 2000-04-29 2001-11-14 上海博德基因开发有限公司 一种新的多肽——人肌球蛋白重链12－14和编码这种多肽的多核苷酸
US6974688B2 (en) * 2001-08-10 2005-12-13 Cytokinetics, Inc. Human smooth muscle myosin heavy chain
US10590452B2 (en) 2017-12-20 2020-03-17 University Of Seoul Industry Cooperation Foundation DNA-Mn hybrid particles and method of manufacturing the same

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0646841A (ja) 1992-07-24 1994-02-22 Kyowa Hakko Kogyo Co Ltd トランスフェリン非要求性細胞

Also Published As

Publication number Publication date
EP0806477B1 (en) 2003-04-09
EP0806477A1 (en) 1997-11-12
FI973104A (fi) 1997-09-24
JP3092944B2 (ja) 2000-09-25
FI973104A0 (fi) 1997-07-24
AU711757B2 (en) 1999-10-21
EP0806477A4 (en) 2000-01-05
KR19980701695A (ko) 1998-06-25
NZ300270A (en) 1998-09-24
US6593304B1 (en) 2003-07-15
AU4496196A (en) 1996-08-14
DE69627307D1 (de) 2003-05-15
DE69627307T2 (de) 2004-03-04
HUP9801762A1 (hu) 1998-11-30
NO973421D0 (no) 1997-07-24
ATE236977T1 (de) 2003-04-15
CA2211468A1 (en) 1996-08-01
WO1996023069A1 (fr) 1996-08-01

Similar Documents

Publication Publication Date Title
DE69434447D1 (de) Für die gentherapie verwendbare plasmide
DE69738791D1 (de) Methode zur behandlung von biopolymeren, mikroorganismen oder anderen materialien, die mehr als einen typ von magnetischen partikeln benutzt.
NO981353L (no) Regulerte gener og anvendelser derav
TR199802676A2 (xx) T�m�rlerin, t�m�rle ilgili hastal�klar�n ve ka�eksinin tedavisi ve �nlenmesi i�in y�ntem.
NO974824L (no) Arteriovenöse og venöse transplantasjonsbehandlinger, fremgangsmåter og blandinger
HUP9902867A3 (en) Therapeutic use of vegf protein or nucleic acid coding same and implant, especially for the treatment of intimal hyperplasia
AU2001258316A1 (en) Process for the fermentative preparation of l-threonine
AU2002311777A1 (en) Method of treating arthritis using lentiviral vectors in gene therapy
NO910982D0 (no) Uratoksydase-aktivt protein, rekombinant gen som koder for det, ekspresjonsvektor, mikroorganismer og transformerteceller.
DK0687184T3 (da) Rekombinante adenoviruser og anvendelse deraf ved genterapi til behandling af øjensygdomme
DE69721824D1 (de) Verwendung von carbonanhydrase-hemmern zur behandlung von makulär-ödemen
NO973421L (no) Rekombinant DNA omfattende DNA som koder for myosin tungkjede SM1-isoformt protein innskutt i vektor DNA, mikroorganisme som inneholder det rekombinante DNA og et middel for behandling av arteriosklerose omfattende det rekombinante DNA
WO1995027070A1 (de) Dna-expressionsvektoren zur verwendung in der gentherapeutischen behandlung von gefässerkrankungen
DE69733948D1 (de) In vivo herstellung von replicativen molekülen
NO981707L (no) Xylanase, oligonukleotidsekvens som koder for xylanase og anvendelse derav
AU4037299A (en) Genetically-modified fibroblasts and the use thereof
ZA949807B (en) Regulatory nucleic acid sequences and uses
NO985558L (no) Ny forbedret formulering for behandling av tromboembolisme
GB9723824D0 (en) Cytostatic agents
AU2002252443A1 (en) Method of treating arthritis using lentiviral vectors in gene therapy
NZ505580A (en) Method of treating immunodeficiences using neutrokine alpha
EP1185306A4 (en) USE OF VIRAL VECTORS AND LOADED MOLECULES FOR GENE THERAPY
ATE309354T1 (de) Replikationsprotein-a-bindendes transkriptionsfaktor (rbt1) und dessen verwendungen
WO2001037853A3 (en) Methods and agents for the inhibition of smooth muscle cell proliferation
PT1133297E (pt) Nova aplicacao terapeutica da 1,6-dimetil-8beta-hidroximetil-10alfa-metoxiergolina